Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2001, p. 2924-2927, Vol. 39, No. 8
Division of Infectious Diseases, Center for
AIDS & STD,1 and Department of
Biostatistics,5 University of Washington,
Public Health-Seattle & King County,3
and Washington State Public Health
Laboratory,2 Seattle, Washington, and
College of Medicine, Howard University, Washington,
D.C.4
Received 9 April 2001/Returned for modification 4 May 2001/Accepted 26 May 2001
Diagnostic tests presently available for Chlamydia
trachomatis have widely varying performance characteristics. To
assess evolving laboratory testing practices since the introduction of nucleic acid amplification tests (NAAT), we surveyed laboratories in
Washington State about their testing practices in 1998 and compared our
findings to a similar survey conducted in 1995. Laboratory directors of
61 (87%) of 70 laboratories performing chlamydial tests in 1998 returned a survey. Between 1995 and 1998, 36 laboratories discontinued
chlamydial testing, and the total number of laboratories performing
tests in the state decreased from 92 to 70, a 24% decline. Of the 36 laboratories that discontinued testing, 25 (69%) had previously used
rapid tests. While no laboratory routinely used NAAT in 1995, ligase
chain reaction (LCR) was used in 23% of laboratories in 1998 and
accounted for 113,624 (36%) of the 318,133 tests performed that year.
Among the remaining 204,509 tests performed in 1998, other tests
employed included DNA probe (29%), enzyme immunoassay (20%), culture
(12%), direct fluorescent antibody assays (3%), and rapid tests
(<1%). The majority (65%) of tests performed in 1998 using
technologies other than LCR or culture were done in laboratories that
did more than 10,000 tests. Cost and loss of revenue to laboratories
were the most frequently cited reasons for not adopting NAAT. We
conclude that in Washington State, NAAT have been rapidly adopted in
larger laboratories, but most patients are still tested with much less
sensitive technologies. Financial constraints represent the major
barrier to more widespread use of DNA amplification tests.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.8.2924-2927.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Evaluation of Laboratory Testing Methods for Chlamydia
trachomatis Infection in the Era of Nucleic Acid
Amplification
*
Corresponding author. Mailing address: Harborview
Medical Center, Box 359931, 325 9th Ave, Seattle, WA 98104-2499. Phone: (206) 731-6829. Fax: (206) 731-4151. E-mail:
golden{at}u.washington.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»